EXACT Sciences (EXAS) has had the highest return since January 1, 2026 by a US stock in the Biotechnology Industry, returning 1,756.8%.
| ASSET | % RETURN |
|---|---|
EXACT Sciences (EXAS) | 1,756.79% |
Adlai Nortye Ltd American Depositary Shares (ANL) | 476.06% |
Cyclerion Therapeutics (CYCN) | 392% |
Erasca (ERAS) | 380.05% |
Edesa Biotech (EDSA) | 323.45% |
Immunitybio (IBRX) | 261.39% |
bioAffinity Technologies (BIAF) | 226.67% |
Sensei Biotherapeutics (SNSE) | 199.71% |
AN2 Therapeutics (ANTX) | 191.96% |
Lisata Therapeutics (LSTA) | 165.61% |
Tango Therapeutics (TNGX) | 144.41% |
Alumis (ALMS) | 139.2% |
Day One Biopharmaceuticals (DAWN) | 130.89% |
Biodesix (BDSX) | 122.93% |
XWELL (XWEL) | 122.92% |
Century Therapeutics (IPSC) | 119.59% |
Adagene (ADAG) | 113.37% |
Longeveron LLC (LGVN) | 111.46% |
Dianthus Therapeutics (DNTH) | 109.19% |
Immunic (IMUX) | 108.63% |
Sutro Biopharma (STRO) | 106.78% |
Moolec Science SA Ordinary Shares (MLEC) | 102.33% |
Eledon Pharmaceuticals (ELDN) | 96.79% |
Zentalis Pharmaceuticals Llc (ZNTL) | 94.81% |
Q32 Bio (QTTB) | 93.33% |
